CMC Biologics and RuiYi (formerly Anaphore) Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody
5/14/2013 9:28:56 AM
More...
|
CMC Biologics Wins 2013 CMO Leadership Award for Innovation, Quality and Reliability
3/19/2013 9:48:44 AM
More...
|
CMC Biologics Establishes Commercial Presence in Japan through Strategic Agreement With Innomedica
9/12/2012 9:46:49 AM
More...
|
CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development
9/10/2012 9:30:55 AM
More...
|
CMC Biologics Announces New General Manager of Copenhagen Facility
8/30/2012 11:04:51 AM
More...
|
CMC Biologics Acquires XOMA Corporation (XOMA)'s Bay Area Manufacturing Facility
7/31/2012 9:57:56 AM
More...
|
CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
6/18/2012 11:16:54 AM
More...
|
CMC Biologics Honored as Finalist for Washington's Manufacturing Company of the Year Award
5/3/2012 11:52:26 AM
More...
|
CMC Biologics Highlights Technical Acumen at Upcoming Conferences
4/17/2012 9:20:43 AM
More...
|
CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
1/5/2012 12:20:39 PM
More...
|
|